Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

29.36
+0.74502.60%
Post-market: 29.450.0900+0.31%19:58 EDT
Volume:4.45M
Turnover:131.80M
Market Cap:3.30B
PE:-25.46
High:30.28
Open:29.19
Low:29.09
Close:28.62
Loading ...
Apr 27, 2022

Major Issues Report

8-K - Current report
Apr 27, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 03, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 28, 2021

Major Issues Report

8-K - Current report
Jul 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 08, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Feb 17, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 17, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals